Gulf deployment was associated with higher prevalence of CWP than deployment elsewhere (OR = 2.03, 95%CI = 1.60 2.58), after adjustment.
Combat deployment was associated with an immediate decline in both mental and physical function.
We found that deployment was associated with a decline in both physical and mental function.
After controlling for pre-deployment function, poorer physical function after deployment was associated with older age, more physical symptoms, blunted systolic blood pressure reactivity and being injured.
Side-by-side deployment was associated with a higher rate of complications and a significantly better stent patency in Kaplan-Meyer analysis but not on multivariate analysis.
Deployment was associated with all four IPV outcomes, and the timing of deployment appeared to be a relevant factor: Remote deployment was an independent risk factor for all four IPV outcomes.
After controlling for pre-deployment physical function, we found that poorer physical function after deployment was associated with older age, lower (i.e., blunted) systolic blood pressure reactivity to stressors, greater concurrent physical symptom severity, and being injured.
After controlling for pre-deployment function, poorer mental function after deployment was associated with younger age, lower social desirability, lower social support, greater physical symptoms and greater PTSD symptoms.
We found that the lactate level before VA ECMO deployment was associated with poor outcome in univariate analysis but not in multivariate analysis (possibly because of a lack of power).
Remote deployment (more than two years previously vs. recent deployment) had an unadjusted association with physical and/or sexual perpetration IPV, while both remote deployment and never having been deployed (vs. recent deployment) was associated with physical and/or sexual IPV victimization.
